Krishana Phoschem Approves Audited FY26 Results and Recommends 5% Final Dividend
Krishana Phoschem reported audited financial results for FY26. The company recommended a final dividend of 5% (₹0.50 per share). Revenue from operations for the year was ₹241,800.11 lakhs. M/s K.C. Moondra & Associates was appointed Cost Auditor and Mrs. Anuradha Dargar as Internal Auditor for FY27.
The approval of financial results and recommendation of dividend are material events for shareholders. The appointments of auditors are routine but necessary corporate actions.
The company reported positive financial results and recommended a dividend, which are generally viewed favorably by investors.
Krishana Phoschem Limited announced the outcome of its Board Meeting held on April 8, 2026. The Board approved the Audited Financial Results for the quarter and year ended March 31, 2026. The company also recommended a final dividend of 5%, or ₹0.50 per equity share of face value ₹10, for the financial year ended March 31, 2026, subject to shareholder approval at the upcoming Annual General Meeting.
Furthermore, the Board appointed M/s K.C. Moondra & Associates as the Cost Auditor and Mrs. Anuradha Dargar as the Internal Auditor for the financial year 2026-27, fixing their respective remunerations.
The audited financial results for the quarter and year ended March 31, 2026, showed a significant increase in revenue from operations to ₹75,549.26 lakhs for the quarter and ₹241,800.11 lakhs for the year, compared to ₹47,288.25 lakhs and ₹135,823.89 lakhs respectively in the previous year. Profit before tax for the quarter stood at ₹7,246.98 lakhs, and for the year at ₹24,102.23 lakhs. Total comprehensive income for the quarter was ₹8,294.04 lakhs and for the year ₹18,001.06 lakhs. The company's assets grew to ₹164,070.50 lakhs as of March 31, 2026, from ₹103,605.70 lakhs in the previous year. The cash flow statement indicated a net cash from financing activities of ₹31,627.45 lakhs for the year ended March 31, 2026.
What to do with a filing like this
Krishana Phoschem Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Krishana Phoschem Limited. Read the original for the full detail.